Pylarify base plus four option years
Ended Awarded Last action
- Contract number
- 36C26224F0237
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $696,466
Award facts
- Contract value 19% obligated
-
- $696,465.52 Current, with exercised options
- $3,673,607.20 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Long Beach, CA 90822, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$295,915 | |
| Original award | $992,381 |
About this award
This is a federal contract award by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract, valued at $3,673,607.20, is for the delivery of PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2029. This award is not set aside for small businesses. Lantheus Holdings, Inc. is the parent company of Progenics Pharmaceuticals and holds several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency (DHA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allowing for the efficient procurement of radiopharmaceuticals and diagnostic imaging agents by federal healthcare providers.
Quick answers
Who was awarded contract 36C26224F0237?
36C26224F0237 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on May 1, 2024.
How much is contract 36C26224F0237 worth?
The government has obligated $696,466 on 36C26224F0237. Its potential value, with all options, is $3,673,607.
Is contract 36C26224F0237 an order under another contract?
Yes. 36C26224F0237 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26224F0237 competed?
The extent of competition for 36C26224F0237 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award